DRUG REGULATORY REFORMS IN INDIA
25th September 2015 (Friday), Juniper Hall, India Habitat Centre, New Delhi
1530 hours Registration & High Tea
INAUGURAL SESSION
1600 – 1605 Welcome Remarks
Dr Shankar Acharya
Honorary Professor, ICRIER; Former Chief Economic Adviser, Government of India
1605 – 1620 Inaugural Address
Dr G N Singh
Drugs Controller General of India, Central Drugs Standard Control Organization
(CDSCO), Ministry of Health and Family Welfare, Government of India
1620 – 1635 Special Address
Dr Ranjit Roy Chaudhury
National Professor of Pharmacology, National Academy of Medical Sciences (NAMS); Former Advisor to Union Minister of Health and Family Welfare, Government of India
1635 – 1650 Keynote Address
Dr Kathleen Holloway
Regional Advisor (Essential Drugs and Medicines), WHO SEARO
PRESENTATION & DISCUSSION SESSION
Chair: Dr Aditya Bhattacharjea, Professor and Head, Department of Economics, Delhi School of Economics
1650 – 1720 Paper Presentation 1
“Administrative Structure and Functions of Drug Regulatory Authorities in India”
Dr Nupur Chowdhury, Consultant, ICRIER [Download Presentation]
1720 – 1750 Paper Presentation 2
“Drug Quality and Safety Issues in India”
Mr Maulik Chokshi, Consultant, ICRIER [Download Presentation]
1750 – 1900 Panel Discussion
Dr Hemant Koshia, Commissioner, Food and Drugs Control Administration, Gujarat
Shri Ravi Prakash Gupta, Controller, Food and Drugs Administration, Chhattisgarh
Ms Susan Winckler, Managing Partner, Leavitt Partners LLC, Washington, DC
Mr D G Shah, Secretary General, Indian Pharmaceutical Alliance
Mr Richard Kingham, Partner, Covington and Burling LLP, Washington, DC
1900 – 1930 Q&A
1930 hours onwards Cocktails & Dinner